Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001415889-25-017421

Options or other derivatives

  • Director acquired 19,959 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2025-06-12 Grant or award · Non-Qualified Stock Option (right to buy) +19,959 19,959 I
Loading xslF345X05/form4-06162025_090600.xml…